31686946|t|Orphan Drugs In Development For The Treatment Of Friedreich's Ataxia: Focus On Omaveloxolone.
31686946|a|Friedreich's Ataxia (FRDA) is a devastating and progressive ataxia, marked by mitochondrial dysfunction and oxidative stress. Nrf2 activators such as omaveloxolone (Omav) modulate antioxidative mechanisms, and thus may be viable therapeutic agents in FRDA.
31686946	49	68	Friedreich's Ataxia	Disease	MESH:D005621
31686946	79	92	Omaveloxolone	Chemical	MESH:C000589490
31686946	94	113	Friedreich's Ataxia	Disease	MESH:D005621
31686946	115	119	FRDA	Disease	MESH:D005621
31686946	154	160	ataxia	Disease	MESH:D001259
31686946	172	197	mitochondrial dysfunction	Disease	MESH:D028361
31686946	220	224	Nrf2	Gene	4780
31686946	244	257	omaveloxolone	Chemical	MESH:C000589490
31686946	259	263	Omav	Chemical	MESH:C000589490
31686946	345	349	FRDA	Disease	MESH:D005621
31686946	Negative_Correlation	MESH:C000589490	MESH:D005621
31686946	Positive_Correlation	MESH:C000589490	4780
31686946	Association	MESH:D005621	4780

